AVTR - Avantor Inc logo

AVTR

Avantor Inc

Avantor Inc supplies critical products and services to the biopharma, healthcare, education, and advanced technology sectors. Its offerings include lab supplies, chemicals, filtration systems, and specialized services like biopharmaceutical development.

โš•๏ธ Healthcare NYSE Listed 2019 $ USD
$1,000 invested 5 years ago โ†’$361today

Score Overview

1 Year
Score
Net Growth-9.02%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth0.14%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.4
Net Growth-200.94%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-11.17%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Score
Net Growth-15x
Net Trend57%
Net Income Consistency
Rev Growth8.62%
Rev Trend57%
Revenue Consistency

See the full market ranking โ†’

Avantor Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 6.39B to $ 6.55B and net income went from $ 116M to -$ 530M. Revenue increased in 2 of those 5 years; net income in 2.

Avantor Inc currently holds a 5-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 13.93โ€”
1 Year2025-08-12
$ 12.6610.03%
5 Years2021-08-12
$ 38.54-63.86%
All Time2019-05-17
$ 14.50-3.93%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 6.56B-$ 578M$ 306M
2025$ 6.55B-$ 530M$ 365M
2024$ 6.78B$ 711M$ 261M
2023$ 6.96B$ 321M$ 262M
2022$ 4.90B$ 686M$ 372M
2021$ 7.38B$ 572M$ 301M
2020$ 6.39B$ 116M$ 286M
IPO2019$ 6.04B$ 37M$ 186M

Explore beyond AVTR

You're looking at Avantor Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies